Re-Engineering the Therapeutic Window: Can Pre-Targeting Overcome the Fundamental Limitations of Conventional Radiopharmaceuticals?

Name: Re-Engineering the Therapeutic Window: Can Pre-Targeting Overcome the Fundamental Limitations of Conventional Radiopharmaceuticals?
Start: 2026-12-02T13:30
Location: Renaissance London Heathrow Hotel

Targeted Radiopharmaceuticals Summit EU 2026 · 2 December 2026 · 13:30

Re-Engineering the Therapeutic Window: Can Pre-Targeting Overcome the Fundamental Limitations of Conventional Radiopharmaceuticals? was a session at Targeted Radiopharmaceuticals Summit EU 2026 on 2 December 2026 in London, with 1 speaker on record.

Speakers

Friedmund Bachmann — Speaker Vice President CMC & Project Lead, OncoOne